Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches
Authors
Keywords
-
Journal
Cardiovascular Toxicology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-21
DOI
10.1007/s12012-022-09721-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations
- (2021) Naser-Aldin Lashgari et al. MOLECULAR BIOLOGY REPORTS
- Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
- (2021) Pushkar Singh Rawat et al. BIOMEDICINE & PHARMACOTHERAPY
- Anti-Inflammatory and Antioxidative Effects of Sumatriptan Against Doxorubicin-Induced Cardiotoxicity in Rat
- (2021) Mohammad Sheibani et al. Acta Medica Iranica
- The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells
- (2021) Yusuke Soma et al. Frontiers in Cardiovascular Medicine
- AC-Mode of Chemotherapy as a Trigger of Cardiac Syndrome X: A Case Study
- (2021) Ashot Avagimyan et al. CURRENT PROBLEMS IN CARDIOLOGY
- Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats
- (2020) Mohammad Sheibani et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
- (2020) Kerstin N. Timm et al. CARDIOVASCULAR DRUGS AND THERAPY
- Molecular Profiling of Human Induced Pluripotent Stem Cell Derived Cells and Their Application for the Drug Safety Study
- (2020) Toshikatsu Matsui et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Effects of doxorubicin‐induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions
- (2020) Nichanan Osataphan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Luteolin attenuates doxorubicin-induced cardiotoxicity by modulating the PHLPP1/AKT/Bcl-2 signalling pathway
- (2020) YanDong Zhang et al. PeerJ
- Sirt4: A Multifaceted Enzyme at the Crossroads of Mitochondrial Metabolism and Cancer
- (2020) Daniela Tomaselli et al. Frontiers in Oncology
- A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes
- (2020) Razan Elfadil Ahmed et al. Frontiers in Cell and Developmental Biology
- Sumatriptan reduces severity of status epilepticus induced by lithium–pilocarpine through nitrergic transmission and 5‐HT 1B/D receptors in rats: A pharmacological‐based evidence
- (2020) Faezeh Eslami et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress
- (2020) Dan Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Natural compounds against doxorubicin‐induced cardiotoxicity: A review on the involvement of Nrf2/ ARE signaling pathway
- (2020) Fatemeh Yarmohammadi et al. PHYTOTHERAPY RESEARCH
- Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling
- (2020) Xiaoli Cheng et al. Biomed Research International
- Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner
- (2020) Wei Yu et al. Cardiovascular Diagnosis and Therapy
- Adriamycin-associated cardiomyopathy
- (2019) Brian W. Hardaway CURRENT OPINION IN CARDIOLOGY
- Doxorubicin‐induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIα to IIβ in human stem cell derived cardiomyocytes
- (2019) Ning Cui et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Sumatriptan protects against myocardial ischaemia–reperfusion injury by inhibition of inflammation in rat model
- (2019) Mohammad Sheibani et al. INFLAMMOPHARMACOLOGY
- Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring
- (2019) Nadine Wenningmann et al. MOLECULAR PHARMACOLOGY
- p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities
- (2019) Jie Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DiOHF Protects Against Doxorubicin-Induced Cardiotoxicity Through ERK1 Signaling Pathway
- (2019) Danqi Chang et al. Frontiers in Pharmacology
- Targeting Extracellular Heat Shock Protein 70 Ameliorates Doxorubicin‐Induced Heart Failure Through Resolution of Toll‐Like Receptor 2–Mediated Myocardial Inflammation
- (2019) Peng Liu et al. Journal of the American Heart Association
- The role of melatonin on doxorubicin-induced cardiotoxicity: A systematic review
- (2019) Masoud Najafi et al. LIFE SCIENCES
- Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?
- (2019) Balaraman Kalyanaraman Redox Biology
- Molecular mechanism of doxorubicin-induced cardiomyopathy – An update
- (2018) Kaviyarasi Renu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Diazoxide Improves Mitochondrial Connexin 43 Expression in a Mouse Model of Doxorubicin-Induced Cardiotoxicity
- (2018) Michela Pecoraro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protective effects of magnesium sulfate against doxorubicin induced cardiotoxicity in rats
- (2018) Mina Khalilzadeh et al. LIFE SCIENCES
- The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy
- (2018) Rita Zilinyi et al. MOLECULES
- Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products
- (2018) Jie Yu et al. PHYTOMEDICINE
- Cardiac differentiation of pluripotent stem cells and implications for modeling the heart in health and disease
- (2018) Harsha D. Devalla et al. Science Translational Medicine
- Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis
- (2018) Reem Ali Shaker et al. BMC Pharmacology & Toxicology
- International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
- (2018) Ksenia Blinova et al. Cell Reports
- Doxorubicin Induces ER Calcium Release via Src in Rat Ovarian Follicles
- (2018) Aziz Ur Rehman Aziz et al. TOXICOLOGICAL SCIENCES
- Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways
- (2018) Dina S. El-Agamy et al. Cancer Management and Research
- Protective effects of agmatine on doxorubicin-induced chronic cardiotoxicity in rat
- (2017) Fatemeh Yarmohmmadi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice
- (2017) Vinodkumar B. Pillai et al. Oncotarget
- Exogenous Hydrogen Sulfide Protects against Doxorubicin-Induced Inflammation and Cytotoxicity by Inhibiting p38MAPK/NFκB Pathway in H9c2 Cardiac Cells
- (2017) Runmin Guo et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes
- (2017) Mari C. Asensio-López et al. PLoS One
- Differential roles of caspase-1 and caspase-11 in infection and inflammation
- (2017) Si Ming Man et al. Scientific Reports
- Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
- (2017) Liqun Zhao et al. Scientific Reports
- Protective effects of taurine on doxorubicin-induced acute hepatotoxicity through suppression of oxidative stress and apoptotic responses
- (2016) Katsuhito Nagai et al. ANTI-CANCER DRUGS
- Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
- (2016) Agnieszka Loboda et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
- (2016) Paul W Burridge et al. NATURE MEDICINE
- Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity
- (2016) Michela Pecoraro et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a
- (2016) Zhan Sun et al. Experimental and Therapeutic Medicine
- Resveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes
- (2016) Mi-Hua Liu et al. Experimental and Therapeutic Medicine
- Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
- (2016) Agnes Maillet et al. Scientific Reports
- Doxorubicin-Mediated Cardiotoxicity: Role of Mitochondrial Connexin 43
- (2015) Michela Pecoraro et al. Cardiovascular Toxicology
- SIRT1 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the Oxidative Stress and p38MAPK Pathways
- (2015) Yang Ruan et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Sulforaphane protects the heart from doxorubicin-induced toxicity
- (2015) Preeti Singh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes
- (2015) Kyle G. Cheung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both Topoisomerase II isoforms
- (2014) Shiwei Deng et al. BMC CANCER
- The FGF-2-triggered protection of cardiac subsarcolemmal mitochondria from calcium overload is mitochondrial connexin 43-dependent
- (2014) Wattamon Srisakuldee et al. CARDIOVASCULAR RESEARCH
- Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment
- (2014) Y. Zhao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Metformin Protects Cardiomyocyte from Doxorubicin Induced Cytotoxicity through an AMP-Activated Protein Kinase Dependent Signaling Pathway: An In Vitro Study
- (2014) Laura C. Kobashigawa et al. PLoS One
- Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase
- (2014) Y. Liu et al. Science Translational Medicine
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- The Role of Nitric Oxide in Doxorubicin-Induced Cardiotoxicity: Experimental Study
- (2013) Ayşenur Bahadır et al. Turkish Journal of Hematology
- Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced CardiotoxicityIn VitroandIn Vivo
- (2012) Hongbo Wang et al. Evidence-based Complementary and Alternative Medicine
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Desferrioxamine Attenuates Doxorubicin-Induced Acute Cardiotoxicity through TFG-β/Smad p53 Pathway in Rat Model
- (2012) Othman A. Al-Shabanah et al. Oxidative Medicine and Cellular Longevity
- Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats
- (2011) El-Sayed M. Ammar et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- The Ryanodine Receptor: A Pivotal Ca2+ Regulatory Protein and Potential Therapeutic Drug Target
- (2011) Angela F. Dulhunty et al. CURRENT DRUG TARGETS
- Mechanisms and management of doxorubicin cardiotoxicity
- (2011) Y. Shi et al. HERZ
- S-diclofenac Protects against Doxorubicin-Induced Cardiomyopathy in Mice via Ameliorating Cardiac Gap Junction Remodeling
- (2011) Huili Zhang et al. PLoS One
- Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity
- (2011) J Huelsenbeck et al. Cell Death & Disease
- Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice
- (2010) Kaushik Vedam et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway
- (2010) Takahiro Horie et al. CARDIOVASCULAR RESEARCH
- Crosstalk of reactive oxygen species and NF-κB signaling
- (2010) Michael J Morgan et al. CELL RESEARCH
- The modulatory effect of lithium on doxorubicin-induced cardiotoxicity in rat
- (2010) Maryam Rahimi_Balaei et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats
- (2010) Huda Alkreathy et al. FOOD AND CHEMICAL TOXICOLOGY
- Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart
- (2010) David Montaigne et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- A concise description of cardioprotective strategies in doxorubicin-induced cardiotoxicityThis article is one of a selection of papers published in a special issue celebrating the 125th anniversary of the Faculty of Medicine at the University of Manitoba.
- (2009) Ana R. Lehenbauer Ludke et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts
- (2009) Vilma A. Sardão et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway
- (2009) Elizabeth D. Brookins Danz et al. FREE RADICAL BIOLOGY AND MEDICINE
- Gap Junctions
- (2009) D. A. Goodenough et al. Cold Spring Harbor Perspectives in Biology
- Acute Doxorubicin Cardiotoxicity Is Associated With p53-Induced Inhibition of the Mammalian Target of Rapamycin Pathway
- (2008) Wuqiang Zhu et al. CIRCULATION
- Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice
- (2008) Alexander Riad et al. EUROPEAN JOURNAL OF HEART FAILURE
- Erythropoietin Pretreatment Protects Against Acute Chemotherapy Toxicity in Isolated Rat Hearts
- (2008) Amandine Ramond et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Late Cardiac Effects of Adjuvant Chemotherapy in Breast Cancer Survivors Treated on Southwest Oncology Group Protocol S8897
- (2008) Patricia A. Ganz et al. JOURNAL OF CLINICAL ONCOLOGY
- Morphine is protective against doxorubicin-induced cardiotoxicity in rat
- (2007) Roohollah Babaei Kelishomi et al. TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More